Internal Medicine, Rheumatology · San Diego, CA
NPI
1609962026
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3633 Camino del Rio S Ste 300
San Diego, CA, 92108
Phone (619) 287-9730
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,680 services
Medicare patients, 2024
181
Average age 73
Drug cost, 2024
$4.9M
2,356 prescriptions
Company payments, 2025
$366K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ara H Dikranian was code J1010 (injection, methylprednisolone acetate, 1 mg), 840 times for 18 patients. In total Ara H Dikranian billed 1,680 services in 22 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 840 | 18 | $0.11 | $88.21 |
| 99214 Office E&M - Established | Office | 415 | 147 | $99.60 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 258 | 118 | $13.24 | $3,415 |
| 99213 Office E&M - Established | Office | 92 | 65 | $69.42 | $6,387 |
| 99204 Office E&M - New | Office | 15 | 15 | $129.36 | $1,940 |
By year: 2022 $67K for 1,048 services; 2023 $59K for 1,185 services; 2024 $57K for 1,680 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ara H Dikranian prescribed most often to Medicare patients was Prednisone, with 280 prescriptions and refills. In total Ara H Dikranian wrote 2,356 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 280 | 516 | 74 | $1,788 |
| Hydroxychloroquine Sulfate Generic | 182 | 428 | 45 | $8,674 |
| Methotrexate Methotrexate Sodium | 151 | 339 | 37 | $3,612 |
| Duloxetine Hcl Generic | 139 | 316 | 35 | $3,700 |
| Celecoxib Generic | 138 | 275 | 44 | $9,055 |
| Pilocarpine Hcl Generic | 67 | 115 | 19 | $6,723 |
| Gabapentin Generic | 64 | 137 | 18 | $1,411 |
| Diclofenac Sodium Generic | 62 | 86 | 21 | $2,149 |
| Enbrel Sureclick Etanercept | 58 | 58 | Under 11 | $434K |
| Meloxicam Generic | 58 | 121 | 29 | $451 |
| Rinvoq Upadacitinib | 54 | 62 | Under 11 | $354K |
| Humira(Cf) Pen Adalimumab | 54 | 57 | Under 11 | $470K |
| Xeljanz Xr Tofacitinib Citrate | 53 | 70 | Under 11 | $410K |
| Alendronate Sodium Generic | 46 | 95 | 14 | $461 |
| Orencia Clickject Abatacept | 44 | 44 | Under 11 | $245K |
Brand drugs: 578 claims; generic drugs: 1,778 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ara H Dikranian $366K ($366K in general payments such as food, travel and fees) from 28 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $93K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 159 | $93K |
| Abbvie Inc. ABBV | 114 | $75K |
| UCB, Inc. UCB.BR | 71 | $40K |
| Genzyme Corporation SNY | 35 | $36K |
| AstraZeneca Pharmaceuticals LP AZN | 46 | $28K |
| Janssen Biotech, Inc. JNJ | 67 | $22K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 34 | $21K |
| Amgen Inc. AMGN | 65 | $17K |
| Lilly USA, LLC LLY | 42 | $17K |
| GlaxoSmithKline, LLC. GSK | 15 | $11K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.